Achaogen: Achaogen Announces Pricing of $15 Million Underwritten Public Offering

(marketscreener.com) SOUTH SAN FRANCISCO, Calif., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, today announced the pricing of an underwritten public offering of 15,000,000 shares...http://www.marketscreener.com/ACHAOGEN-INC-15991095/news/Achaogen-Announces-Pricing-of-15-Million-Underwritten-Public-Offering-28015940/?utm_medium=RSS&utm_content=20190215